Literature DB >> 1927817

Primary sclerosing cholangitis: value of cholangiography in determining the prognosis.

D A Craig1, R L MacCarty, R H Wiesner, P M Grambsch, N F LaRusso.   

Abstract

We studied cholangiograms in 129 patients with primary sclerosing cholangitis (PSC) to determine if there was a correlation between any of the findings and the prognosis of the disease. The grade, length, and extent of strictures, the degree of bile duct dilatation, and the distribution of lesions were evaluated. Survival curves were generated to test the association of these radiologic signs with subsequent survival. High-grade intrahepatic duct strictures (greater than 75% narrowing) were associated with a 19% decrease in 3-year survival (p = .05) compared with lower-grade strictures. Diffuse intrahepatic strictures (involving greater than 25% of the ducts) were associated with a 16% decrease in 3-year survival (p = .012) compared with localized strictures. Statistically insignificant (p greater than .05) but measurable decreases in survival were observed with high-grade extrahepatic duct strictures, diffuse involvement of the extrahepatic ducts, long confluent strictures anywhere in the biliary tree, and marked dilatation of the intrahepatic ducts. In general, intrahepatic duct disease was found to have greater prognostic significance than extrahepatic duct disease. High-grade strictures and diffuse strictures of the intrahepatic ducts were found to be indicators of a poor prognosis in PSC and were more predictive of a poor prognosis than was extrahepatic duct disease.

Entities:  

Mesh:

Year:  1991        PMID: 1927817     DOI: 10.2214/ajr.157.5.1927817

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis.

Authors:  Takashi Tomiyama; Kazushige Uchida; Mitsunobu Matsushita; Tsukasa Ikeura; Toshiro Fukui; Makoto Takaoka; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2010-12-25       Impact factor: 7.527

2.  Endoscopic treatment of biliary tract disease prior to orthotopic liver transplantation.

Authors:  Roshan Shrestha; David M S Grunkemeier
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

3.  MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes.

Authors:  Candice A Bookwalter; Sudhakar K Venkatesh; John E Eaton; Thomas D Smyrk; Richard L Ehman
Journal:  Abdom Radiol (NY)       Date:  2018-12

Review 4.  Controversies in the management of primary sclerosing cholangitis.

Authors:  Jeremy S Nayagam; Stephen P Pereira; John Devlin; Phillip M Harrison; Deepak Joshi
Journal:  World J Hepatol       Date:  2016-02-18

5.  Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.

Authors:  C Y Ponsioen; S M E Vrouenraets; W Prawirodirdjo; R Rajaram; E A J Rauws; C J J Mulder; J B Reitsma; S H Heisterkamp; G N J Tytgat
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 6.  Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.

Authors:  Kunjam Modha; Udayakumar Navaneethan
Journal:  World J Hepatol       Date:  2015-04-18

7.  Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines.

Authors:  Hideki Yasuda; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Koichi Hirata; Yasutoshi Kimura; Keita Wada; Fumihiko Miura; Masahiko Hirota; Toshihiko Mayumi; Masahiro Yoshida; Masato Nagino; Yuichi Yamashita; Serafin C Hilvano; Sun-Whe Kim
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

Review 8.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

9.  Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis.

Authors:  Takayoshi Nishino; Hiroyasu Oyama; Etsuko Hashimoto; Fumitake Toki; Itaru Oi; Makio Kobayashi; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

10.  Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis.

Authors:  Bojan D Petrovic; Paul Nikolaidis; Nancy A Hammond; John A Martin; Polina V Petrovic; Pankaja M Desai; Frank H Miller
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.